D-0208-2025 Class III
FDA drug recall D-0208-2025 was initiated by Appco Pharma LLC on Jan 16, 2025 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet Affected quantity: 1380 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 29, 2025
- Initiation Date
- Jan 16, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1380 bottles
Product description
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Reason for recall
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Distribution pattern
Nationwide USA.
Code information
Lot #: 2402101UR, Exp 02/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0208-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026